According to our analysis, TSP50 was expressed differently in distinct breast cancer cells and molecular subtypes, and highly expressed TSP50 was significantly associated with the shorter OS and DMFS, indicating that TSP50 may function as a potential diagnostic indicator for breast cancer and deserves further experimental validation. Here, PRSS50 is linked to breast carcinoma.